CNTX
Context Therapeutics Inc.
$2.34+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Context Therapeutics Inc. (CNTX) is a publicly traded company with 4 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 14 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-19 | Levit Alex C. | CLO | Award | 270,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-23 | 2026-02-19 | Minai-Azary Jennifer Lynn | CFO | Award | 275,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-23 | 2026-02-19 | Chagin Karen Deborah | CMO | Award | 290,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-23 | 2026-02-19 | Lehr Martin A. | CEO | Award | 815,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-12 | West Linda | Director | Award | 123,500 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-12 | Stacey Jennifer Evans | Director | Award | 123,500 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-12 | Pasternak Andy | Director | Award | 138,900 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-12 | Walker Luke Nathaniel | Director | Award | 123,500 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-12 | Smith Karen L. | Director | Award | 123,500 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-12 | Kantoff Philip W. | Director | Award | 123,500 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.